THOMAS MONATH to United States
This is a "connection" page, showing publications THOMAS MONATH has written about United States.
Connection Strength
0.342
-
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses. 2023 12 28; 16(1).
Score: 0.076
-
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic. Vaccine. 2017 08 16; 35(35 Pt A):4465-4469.
Score: 0.048
-
Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States. Am J Trop Med Hyg. 2010 May; 82(5):919-21.
Score: 0.029
-
In Memoriam. Patricia Ann Webb (1925-5005). Arch Virol. 2005 Jun; 150(6):1268-70.
Score: 0.021
-
Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser. Vector Borne Zoonotic Dis. 2005; 5(3):300-4.
Score: 0.020
-
Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. Am J Trop Med Hyg. 2004 Nov; 71(5):639-45.
Score: 0.020
-
Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis. 2002 May 15; 34(10):1369-78.
Score: 0.017
-
Editorial: jennerian vaccination against West Nile virus. Am J Trop Med Hyg. 2002 Feb; 66(2):113-4.
Score: 0.017
-
Prospects for development of a vaccine against the West Nile virus. Ann N Y Acad Sci. 2001 Dec; 951:1-12.
Score: 0.016
-
Strengthening the biological weapons convention. Science. 1998 Nov 20; 282(5393):1423.
Score: 0.013
-
Does restricted distribution limit access and coverage of yellow fever vaccine in the United States? Emerg Infect Dis. 1998 Oct-Dec; 4(4):698-702.
Score: 0.013
-
Safety and immunogenicity of the rVSV?G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect Dis. 2017 08; 17(8):854-866.
Score: 0.012
-
Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis. 1990 May; 161(5):878-82.
Score: 0.007
-
St. Louis encephalitis: lessons from the last decade. Am J Trop Med Hyg. 1987 Nov; 37(3 Suppl):40S-59S.
Score: 0.006
-
Aedes albopictus, an exotic mosquito vector in the United States. Ann Intern Med. 1986 Sep; 105(3):449-51.
Score: 0.006
-
Genetic heterogeneity among Saint Louis encephalitis virus isolates of different geographic origin. Virology. 1981 Oct 30; 114(2):319-32.
Score: 0.004
-
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics. 1999 Oct; 104(4 Pt 1):942-50.
Score: 0.004
-
Risk of Helicobacter pylori infection among long-term residents in developing countries. Am J Trop Med Hyg. 1999 Feb; 60(2):267-70.
Score: 0.003
-
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ. 1975; 52(4-6):577-92.
Score: 0.003
-
Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Prog Clin Biol Res. 1983; 123:31-41.
Score: 0.001
-
Human arboviral infections in the United States in 1980. J Infect Dis. 1982 Feb; 145(2):283-6.
Score: 0.001
-
Experimental transmission of Rocio virus by mosquitoes. Am J Trop Med Hyg. 1981 Mar; 30(2):465-72.
Score: 0.001
-
Geographic variation among St. Louis encephalitis virus strains in the viremic responses of avian hosts. Am J Trop Med Hyg. 1980 Nov; 29(6):1411-9.
Score: 0.001
-
Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification. Ann N Y Acad Sci. 1980; 354:219-37.
Score: 0.001